MT-CO1 and prostate cancer: Further data demonstrate that both germ-line and somatic mtDNA mutations contribute to prostate cancer, and about 11% of all prostate cancer patients harbored mt-CO1 (mitochondrially encoded cytochrome c oxidase I) mutations [41].